Related Experiment Video
Updated: Aug 29, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Management of patients with stunned myocardium associated with subarachnoid hemorrhage
Rajan Jain1, John Deveikis, Byron G Thompson
1Division of Neuroradiology and Department of Radiology, University of Michigan Health System, Ann Arbor, MI, USA.
Insights
Neurogenic stunned myocardium can cause reversible cardiac failure after aneurysmal subarachnoid hemorrhage. Endovascular treatment of aneurysms and vasospasm management improve patient outcomes.
Area of Science:
- Neurology
- Cardiology
- Critical Care Medicine
Background:
- Cardiac complications are common after aneurysmal subarachnoid hemorrhage (aSAH).
- Electrocardiographic changes are seen in 50-100% of aSAH cases, with arrhythmias and myocardial infarction being less frequent.
- Distinguishing myocardial infarction from neurogenic stunned myocardium (NSM) is crucial, as NSM is reversible.
Observation:
- Four patients with no prior cardiac history developed cardiac failure due to NSM after endovascular treatment for aSAH.
- All presented with left ventricular dysfunction, ECG changes, elevated cardiac enzymes, and were diagnosed with myocardial infarction.
- One patient had normal coronary angiography, suggesting a non-coronary cause for cardiac dysfunction.
Findings:
- Neurogenic stunned myocardium is a reversible cause of cardiac failure following aSAH.
- Symptomatic vasospasm occurred frequently in these patients, complicating management.
- Endovascular aneurysm treatment and balloon angioplasty for vasospasm were utilized.
Implications:
- Aggressive management, including endovascular therapy and vasospasm treatment, can lead to recovery from reversible cardiac complications post-aSAH.
- Understanding NSM is vital for appropriate diagnosis and treatment in aSAH patients.
- Optimizing hemodynamic therapy can be challenging in patients with compromised cardiac output and volume status.
Abstract:
Cardiac complications are well known after aneurysmal subarachnoid hemorrhage. Electrocardiographic changes occur in 50% to 100% of such cases. Arrhythmias, left ventricular dysfunction, and frank myocardial infarction are infrequently observed. Myocardial infarction must be differentiated from neurogenic stunned myocardium, which is a reversible condition. From 1996 to 2001, 105 patients with aneurysmal subarachnoid hemorrhage underwent endovascular treatment at the University of Michigan. Of these, four patients with no history of cardiac disease experienced cardiac failure related to neurogenic stunned myocardium. All had signs of left ventricular dysfunction, electrocardiographic changes, and elevated cardiac enzymes. Three had pulmonary edema at presentation. All were diagnosed with myocardial infarction. One underwent coronary angiography, which was normal. All were considered poor surgical candidates and underwent endovascular treatment of the aneurysms. Three of four patients developed symptomatic vasospasm, and two required balloon angioplasty. Three patients achieved good outcomes. The eldest died from severe vasospasm that was unresponsive to angioplasty. Reversible cardiac failure associated with subarachnoid hemorrhage may be due the neurogenic stunned myocardium. Frequent symptomatic vasospasm occurs, possibly related to poor cardiac output and the inability to optimize hyperdynamic hypervolemic therapy, particularly with compromised volume status. These patients can be treated with endovascular therapy of the aneurysms and balloon angioplasty as needed. With aggressive management, patients can recover from these reversible cardiac complications.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Aneurysm IV: Nursing Management
Acute Coronary Syndrome V: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Hemorrhagic Stroke ll: Pathophysiology
